Balderton Capital's Investment Rationale for Kaia Health

Balderton Capital on Kaia Health: Balderton believes Kaia Health's technology can provide millions of chronic pain sufferers with best-in-class, clinically

Investment Rationale · Balderton Capital

Investment thesis

Balderton believes Kaia Health's technology can provide millions of chronic pain sufferers with best-in-class, clinically validated solutions from their own homes.

Kaia Health is helping to tackle this through its revolutionary technology, which we believe could offer millions of chronic-pain sufferers best-in-class clinical solutions from the comfort of their own homes.

Product

Kaia Health offers a mobile app using computer vision and AI to monitor exercises and provide real-time natural language feedback without extra hardware.

It’s the only mobile app that uses computer vision to offer patients real-time feedback.

Traction

Kaia Health's back pain app has been adopted by over 250,000 individuals and organizations across Europe and the United States since 2016.

Its Kaia back pain app has been rapidly adopted by over 250,000 individuals as well as organisations across Europe and the US.

Business model

Kaia Health partners with major health insurance companies, including Germany's largest insurer BARMER, to provide its digital therapeutic app free to policyholders.

This includes some of Europe’s biggest health insurance companies, such as BARMER, Germany’s largest, which offers the service free to members.

What founders can learn

  • The traction evidence that carried weight: Balderton Capital wrote that Kaia Health's back pain app has been adopted by over 250,000 individuals and organizations across Europe and the United States since 2016.
  • How the model was assessed: Balderton Capital wrote that Kaia Health partners with major health insurance companies, including Germany's largest insurer BARMER, to provide its digital therapeutic app free to policyholders.

Source and provenance

Investment Rationale published by Balderton Capital on balderton.com (first-party source). Read the original

Related